drugset / Trial / NCT00672607

a Clinical Trial to Evaluate the Efficacy and Safety of Agnucaston Tablets in the Treatment of Premenstrual Syndrome (PMS)

NCT00672607 ↗

Phase 2 Completed 217 enrolled Schwabe-Wenex International Ltd
RandomizedParallel-groupQuadruple-blindTreatment

Summary

To compare the efficacy and safety of Agnucaston tablets with placebo for the treatment of Premenstrual Syndrome (PMS) and assess if Agnucaston tablets are superior to placebo on efficacy or not.

Timeline

Start
2005-02
Primary completion
2007-01
Completion
2007-01

Drugs

EvaluationDrugModalityDoseRoute
Subject extracts of Vitex agnus castus Unknown 1 unknown Oral

Indications